Pharma stocks with high momentum and durability with rising operating profit margin in Q2 execution history

Pharma stocks with high momentum and durability with rising operating profit margin in Q2

This screener shows pharmaceuticals stocks with high Trendlyne momentum and durability scores with rising operating profit margin in Q2FY25

Last Updated: 26 Jun 2025, 11:45 a.m. (IST)

Run new strategy/screener backtest

Choose Date Range and Frequency

Portfolio Review Frequency

Start Date

End Date

Choose Stock Universe

Select Stock Universe

Current universe constituents are applied throughout the backtest.

Select Benchmark

Advanced Sorting

You can only run backtest on stock screeners you own.

This screen query contains one or more premium fields for backtest.
Please contact us for subscription of premium parameters access or remove those fields to run backtest.

Pharma stocks with high momentum and durability with rising operating profit margin in Q2

Run new strategy/screener backtest

Previous back tests